Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and ...

Current guidelines recommend dual antiplatelet therapy, a combination of aspirin and a P2Y 12 inhibitor, for 6–12 months after percutaneous coronary intervention with drug-eluting stent ...

It is crucial for patients to communicate with their healthcare provider about any unusual symptoms and to follow dosing instructions carefully to minimize these risks while benefiting from the ...

The following is a summary of “Bleeding complications, coagulation disorders, and their management in acute myocardial ...

This unique dual formulation provides the potential benefit for smooth transition from short-term intravenous to long-term oral antiplatelet therapy. It has a plasma half-life of approximately 12 ...

Screening for these risk factors is important for preventing their additive stroke risk. Antiplatelet therapy, such as ...

Myocardial Infarction, Cardiovascular Disease, Prevention, Challenges, Review Abdin, A. (2024) Myocardial Infarction and the Prevention Strategies Keeping it at Bay: A Narrative Review. Open Access ...

Heart disease is a type of cardiovascular disease that affects the heart’s structure and function. Several different heart ...

Sahajanand Medical Technologies successfully completed enrollment of 1,550 patients for the Multivessel TALENT trial, ...

A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S ...

Notably, two patients suffered strokes within two months of starting daprodustat (Cases 2 and 3). One patient, despite being ...

VMPL Mumbai Maharashtra [India] October 3 Sahajanand Medical Technologies SMT is excited to announce the successful ...